Van Huis; Chad A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Huis; Chad A..The latest application filed is for "benzenesulfonamido and related compounds for use as agonists of rory and the treatment of disease".

Company Profile

1.16.15

Van Huis; Chad A. - Hartland MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods Grant 10,532,088 - Glick , et al. Ja	2020-01-14
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,377,768 - Aicher , et al. A	2019-08-13
Benzenesulfonamido and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 10,189,777 - Aicher , et al. Ja	2019-01-29
Indazole guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 9,920,012 - Hurd , et al. March 20, 2	2018-03-20
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE App 20170190659 - Aicher; Thomas D. ; et al.	2017-07-06
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease Grant 9,657,033 - Aicher , et al. May 23, 2	2017-05-23
Saturated acyl guanidine for inhibition of F.sub.1F.sub.0-ATPase Grant 9,580,391 - Hurd , et al. February 28, 2	2017-02-28
Adoptive Cellular Therapy Using an Agonist of Retinoic Acid Receptor-Related Orphan Receptor Gamma & Related Therapeutic Methods App 20170007686 - Glick; Gary D. ; et al.	2017-01-12
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease Grant 9,512,111 - Glick , et al. December 6, 2	2016-12-06
Pyridonyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 9,370,507 - Glick , et al. June 21, 2	2016-06-21
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease Grant 9,266,827 - Aicher , et al. February 23, 2	2016-02-23
Pyridonyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20150335625 - Glick; Gary D. ; et al.	2015-11-26
Cycloalkyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 9,169,199 - Hurd , et al. October 27, 2	2015-10-27
Pyrazolyl guanidine F.sub.1F.sub.0-atpase inhibitors and therapeutic uses thereof Grant 9,139,532 - Glick , et al. September 22, 2	2015-09-22
Indazole Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20150152063 - Hurd; Alexander R. ; et al.	2015-06-04
BICYCLIC SULFONE COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20150126493 - Aicher; Thomas D. ; et al.	2015-05-07
Saturated Acyl Guanidine For Inhibition Of F1f0-atpase App 20150119439 - Hurd; Alexander R. ; et al.	2015-04-30
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20150111877 - Aicher; Thomas D. ; et al.	2015-04-23
Pyridonyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 9,000,014 - Glick , et al. April 7, 2	2015-04-07
N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20140088094 - Glick; Gary D. ; et al.	2014-03-27
Pyridonyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20140051727 - Glick; Gary D. ; et al.	2014-02-20
Cycloalkyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20130331392 - Hurd; Alexander R. ; et al.	2013-12-12
Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20130324536 - Glick; Gary D. ; et al.	2013-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.